Related Experiment Video

Updated: Sep 14, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

[Cerebral venous thrombosis and factor V Leiden mutation]

Qiang Meng1, Chuanqiang Pu

  • 1Department of Neurology, Chinese PLA General Hospital, Beijing 100853, China.

Zhonghua Yi Xue Za Zhi
|April 16, 2002
PubMed

Insights

Factor V Leiden mutation is not a significant risk factor for cerebral venous thrombosis in the Chinese population. This genetic mutation was not detected in patients or controls studied.

Area of Science:

  • Genetics
  • Hematology
  • Neurology

Context:

  • Cerebral venous thrombosis (CVT) is a rare but serious condition.
  • The role of genetic factors, such as factor V Leiden mutation, in CVT pathogenesis is under investigation.
  • Prevalence of genetic risk factors may vary across different ethnic groups.

Purpose:

  • To determine the association between factor V Leiden mutation and cerebral venous thrombosis (CVT) specifically in the Chinese population.
  • To investigate the frequency of factor V Leiden mutation in Chinese patients diagnosed with CVT compared to healthy controls.

Summary:

  • A study involving 20 Chinese patients with CVT and 50 controls was conducted.
  • Polymerase chain reaction (PCR) and Mnl I restriction enzyme analysis were used to screen for the factor V Leiden mutation.
  • The factor V Leiden mutation was absent in all participants, indicating no genetic link in this cohort.

Impact:

  • This research suggests that factor V Leiden mutation is unlikely to be a primary genetic risk factor for cerebral venous thrombosis in China.
  • Findings contribute to understanding the genetic landscape of CVT in East Asian populations.
  • May inform future diagnostic and risk stratification strategies for CVT.
Abstract

More Related Videos

Isolation and Cannulation of Cerebral Parenchymal Arterioles09:49

Isolation and Cannulation of Cerebral Parenchymal Arterioles

Published on: May 23, 2016

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis07:34

Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis

Published on: December 30, 2025

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...